Ahiphena (Opium) ↔ Opioid Receptor Pharmacology, Overdose Management & NDPS Legal Status
Ahiphena (crude opium) is a medieval addition to the materia medica whose classical antidiarrhoeal, analgesic, hypnotic and antitussive uses map with unusual precision onto real mu-opioid receptor pharmacology, but it is governed as a narcotic drug under the NDPS Act 1985 rather than as an ordinary poison, and its most dangerous traditional use -- quieting infants -- kills by respiratory depression.
IN PLAIN LANGUAGE
Opium (ahiphena) is the dried latex of the opium poppy and the classical source of morphine and codeine. Ayurveda has long used purified opium for diarrhoea, pain, cough and insomnia. Modern medicine explains exactly why these uses work -- it binds the body's own pain-relief receptors -- and exactly why it is dangerous: too much stops breathing. It is tightly controlled by law in India, and it must never be given to an infant or young child.
Ayurveda offers a purified, dose-controlled analgesic/antidiarrhoeal/hypnotic within compound formulations and a long record of use for shoola, atisara and anidra. Modern medicine offers precise receptor pharmacology, a specific rapidly-acting antidote (naloxone), structured opioid substitution therapy for dependence, and a legal framework (the NDPS Act) that both controls misuse and, since 2014, tries to preserve access for legitimate pain relief.
WHEN TO SEEK CARE
Get emergency care immediately for slow, shallow or irregular breathing, pinpoint pupils, or reduced consciousness in anyone who may have taken opium or an opioid -- this is a medical emergency treatable with naloxone. Anyone with opioid dependence should be referred to a de-addiction or opioid substitution programme, not moralised at or supplied informally.
🔴 REFER IMMEDIATELY
- Pinpoint pupils, slow/shallow/irregular breathing and reduced consciousness (classical opioid overdose triad)
- Normal or dilated pupils with inadequate breathing after possible opioid exposure (miosis is not invariable, especially in severe hypoxia or mixed overdose)
- A neonate with high-pitched cry, irritability, tremor, poor feeding, vomiting or seizures born to a dependent mother (neonatal abstinence syndrome)
- Any infant or young child given opium or an opium-containing preparation
- Resumption of a previous opioid dose after a period of abstinence (loss of tolerance -- the commonest cause of fatal relapse overdose)
- Any suspected opioid overdose -- immediate emergency care and naloxone
- Any disclosed opioid dependence -- referral to a de-addiction/opioid substitution programme
- Any infant exposed to opium
- Undiagnosed acute abdominal pain (opioids mask the signs of an acute abdomen)
Never do this
Never give opium or any opium-containing preparation to an infant or child. Never possess, stock, dispense or accept crude opium outside the licensed framework -- this is a criminal offence under the NDPS Act, not a professional irregularity. Do not withhold legitimate opioid analgesia from a patient in severe pain (e.g. cancer pain) out of fear of the law; use the essential-narcotic-drug/palliative-care licensing route instead.
🟢 SUITABLE FOR ROUTINE / COLLABORATIVE CARE
AYURVEDA SCOPE
Shodhita ahiphena at classical matra (30-125 mg in divided doses) as a component of compound formulations for atisara/pravahika, shoola, kasa/shwasa and anidra, obtained only through licensed channels and dispensed with full awareness of tolerance and dependence risk.
MODERN MEDICINE SCOPE
Opioid receptor pharmacology and dose-controlled analgesics/antitussives/antidiarrhoeals (including opium-derived drugs such as morphine, codeine and loperamide); naloxone for overdose; opioid substitution therapy and palliative-care access to morphine under the NDPS Act's essential-narcotic-drug provisions.
COLLABORATIVE SCOPE
Recognising that ahiphena-containing classical formulations are, pharmacologically, low-dose opioid preparations, and applying the same overdose vigilance, tolerance/dependence awareness, and legal handling to them as to any opioid medicine.
Sign in to read the full comparison
The plain-language summary and safety guidance above are free for everyone. The 10-dimension scholarly comparison needs an account.
Sign in